Both pretreatment and posttreatment CD4+IL-10+Treg proportions of this current study were higher than the normal range (0.01 × 109‐0.03 × 109/L), suggesting that CD4+IL-10+Tregs could be involved in the development of AD. This evidence concerns the gene IL10 and Alzheimer disease.